Idaho Sperm Bank Privacy Laws Checklist: What Donors, Recipients, and Clinics Need to Know

This checklist distills the Idaho rules that most affect sperm banks, donors, and recipient families—and how they intersect with federal screening standards and ethical guidance. It is general information, not legal advice. Wherever possible, we cite the controlling Idaho statutes and FDA requirements that clinics in Idaho must already follow.

Semen Donation Restrictions

Idaho’s artificial insemination regulations set bright-line limits on who may donate and how care is delivered. A person may not donate semen if he knows he has a venereal disease or a disease or defect known to be transmissible by genes. This prohibition squarely targets transmissible genetic diseases and active sexually transmitted infections that could endanger recipients or offspring. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-54/section-39-5404/))

Only physicians licensed in Idaho—or personnel acting under their supervision—may select gamete donors and perform artificial insemination. This requirement ensures medical oversight from screening through procedure. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-54/section-39-5402/))

Written informed consent is mandatory. Artificial insemination may not be performed without the woman’s prior written request and consent and, if she is married, her husband’s prior written request and consent; there are also notice requirements to the physician after birth. Clinics should reflect these consent and notice steps in their intake packets and workflow. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-54/section-39-5403/))

HIV Testing Requirements

Idaho law requires every hospital, bank, or storage facility that accepts semen donations to use reasonable means to detect whether a donor has antibodies to HTLV‑III—the statute’s historical term for the virus that causes AIDS—before any use in artificial insemination. In practice, this aligns with modern HIV antibody testing and exclusion of any reactive specimens. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-54/section-39-5408/))

Beyond state law, all Idaho programs must meet FDA rules for donors of reproductive cells and tissues. Required infectious disease testing includes HIV‑1/2 (serology and NAT), hepatitis B and C, syphilis, HTLV‑I/II, and, for reproductive HCT/P donors, screening for Chlamydia trachomatis and Neisseria gonorrhoeae. Anonymous semen donations also trigger a six‑month re‑testing requirement before release. ([fda.gov](https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/testing-donors-human-cells-tissues-and-cellular-and-tissue-based-products-hctp-specific-requirements?utm_source=openai))

Genetic Testing Privacy Act Overview

Idaho’s Genetic Testing Privacy Act protects genetic information confidentiality primarily in the employment context. Employers may not request genetic testing, require releases, or use private genetic information when making employment decisions. Violations are enforced by the Idaho Attorney General, who may seek injunctions and civil penalties; there is no private right of action in the statute. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-83/section-39-8303/?utm_source=openai))

Recent amendments add a cybersecurity and supply‑chain dimension: Idaho medical and research facilities are prohibited from using certain genetic sequencers and genetic analysis software produced by “foreign adversary” entities, with specified timelines for removal and limited reimbursement. Clinics performing genetic carrier screening or other analyses should confirm compliance with this equipment ban. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-83/section-39-8305/))

Genetic Testing Privacy Act Overview

Idaho’s Genetic Testing Privacy Act protects genetic information confidentiality primarily in the employment context. Employers may not request genetic testing, require releases, or use private genetic information when making employment decisions. Violations are enforced by the Idaho Attorney General, who may seek injunctions and civil penalties; there is no private right of action in the statute. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-83/section-39-8303/?utm_source=openai))

Recent amendments add a cybersecurity and supply‑chain dimension: Idaho medical and research facilities are prohibited from using certain genetic sequencers and genetic analysis software produced by “foreign adversary” entities, with specified timelines for removal and limited reimbursement. Clinics performing genetic carrier screening or other analyses should confirm compliance with this equipment ban. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-83/section-39-8305/))

Disclosure of Donor Medical Information

Idaho does not mandate disclosure of a donor’s identity to recipients, and programs generally share non‑identifying donor medical information that is relevant to reproductive risk. Ethical guidance urges clinics and banks to gather, maintain, and permanently store medical and genetic information, and to be transparent about what non‑identifying details they will release to recipients and, later, to donor‑conceived people. ([prod.asrm.org](https://prod.asrm.org/practice-guidance/ethics-opinions/informing-offspring-of-their-conception-by-gamete-or-embryo-donation-an-ethics-committee-opinion-2018/?utm_source=openai))

Under Idaho’s Gestational Agreements Act, a gestational agreement may authorize sharing a gamete donor’s medical information with a child born under the agreement. If the donor wishes to remain anonymous, only non‑identifying medical details may be disclosed. This provision helps recipients plan for future health disclosures without compromising gamete donor anonymity. ([law.justia.com](https://law.justia.com/codes/idaho/2024/title-7/chapter-16/section-7-1612/))

Important reality check: absolute gamete donor anonymity cannot be guaranteed in the modern era of direct‑to‑consumer DNA databases. Programs can provide de‑identified profiles, but genetic matching can still uncover identities. Set expectations during counseling and consents. ([integration.asrm.org](https://integration.asrm.org/globalassets/_asrm/practice-guidance/ethics-opinions/pdf/interests_obligations_and_rights_in_gamete_and_embryo_donation.pdf?utm_source=openai))

Donor Rights and Legal Protections

Idaho law states that a sperm donor has no parental rights, obligations, or interests regarding a child conceived through artificial insemination. Likewise, the child has no legal rights or obligations toward the donor. If a married woman undergoes artificial insemination with her husband’s written consent, he is treated for all legal purposes as if he were the natural father. These clear allocations reduce post‑birth disputes. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-54/section-39-5405/))

Medical Examination Protocols for Donors

Federal rules require a donor eligibility determination that includes a comprehensive risk assessment (review of relevant medical records, a donor medical history interview, and findings focused on communicable disease risk), plus lab testing using FDA‑cleared screening assays. Idaho clinics rely on these baseline medical examination requirements to protect recipients and offspring. ([law.cornell.edu](https://www.law.cornell.edu/cfr/text/21/1271.75?utm_source=openai))

Professional guidance adds depth: ASRM recommends a complete physical exam, semen analysis with freeze‑thaw assessment, HIV/STI risk screening, and appropriate genetic carrier screening—with informed consent that explains test scope, limits, and the possibility of re‑contact if new health information emerges. ([asrm.org](https://www.asrm.org/practice-guidance/practice-committee-documents/guidance-regarding-gamete-and-embryo-donation?utm_source=openai))

Storage and Donation Options for Frozen Material

Frozen sperm storage protocols must meet FDA tissue rules. Anonymous donor semen is quarantined and may not be released until the donor is re‑tested at least six months after donation and found eligible. Containers carry a distinct identification code and required eligibility statements so that any vial can be traced and properly released. ([law.cornell.edu](https://www.law.cornell.edu/cfr/text/21/1271.60?utm_source=openai))

Directed donation (to a known, specifically identified recipient) follows different release pathways. Federal rules allow use of reproductive cells from a directed reproductive donor even if the donor is ineligible, provided specific biohazard and risk‑warning labels accompany the specimen. Many programs still adopt added safeguards; for example, ASRM recommends a 35‑day quarantine with re‑testing for directed donors even though FDA does not require the six‑month hold in that setting. ([ecfr.io](https://ecfr.io/Title-21/Section-1271.65?utm_source=openai))

Autologous (self) storage for fertility preservation is separately addressed in FDA exceptions, but clinics should still document screening steps, labeling, and disclosures consistent with Part 1271.90 when those vials are later repurposed for directed use. ([ecfr.io](https://ecfr.io/Title-21/Section-1271.90?utm_source=openai))

Conclusion

If you operate, donate, or receive care in Idaho, anchor your processes in the state’s artificial insemination statutes, pair them with FDA donor eligibility and testing rules, and communicate clearly about genetic information confidentiality, gamete donor anonymity limits, and frozen sperm storage protocols. Doing so keeps you aligned with both the letter of the law and the best interests of donor‑conceived families. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-54/section-39-5402/))

FAQs.

What are the privacy protections for sperm donors in Idaho?

Idaho law gives donors strong parentage protections—donors have no parental rights or obligations to a child conceived by artificial insemination—and programs ordinarily release only non‑identifying medical details to recipients. Separate employment‑law provisions restrict employers from accessing or using private genetic information. Nonetheless, complete anonymity cannot be guaranteed in the age of consumer DNA testing. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-54/section-39-5405/))

How does the Genetic Testing Privacy Act affect sperm donation?

The Act chiefly governs employers: it bars them from requiring genetic tests, demanding releases, or using private genetic data in employment decisions, with enforcement by the Attorney General. For clinics, the 2024 amendment also prohibits use of certain “foreign adversary” genetic sequencers and analysis software—relevant to any in‑house genetic screening platforms. ([law.justia.com](https://law.justia.com/codes/idaho/title-39/chapter-83/section-39-8304/))

Are recipients entitled to donor medical information?

Idaho does not require release of a donor’s identity, but ethical guidance supports providing recipients with non‑identifying medical and genetic history that informs risk (and maintaining those records permanently). Under the Gestational Agreements Act, a contract may authorize sharing a donor’s medical information with the child; if the donor elects anonymity, only non‑identifying details may be disclosed. ([prod.asrm.org](https://prod.asrm.org/practice-guidance/ethics-opinions/informing-offspring-of-their-conception-by-gamete-or-embryo-donation-an-ethics-committee-opinion-2018/?utm_source=openai))

What testing is required before sperm donation?

FDA regulations require donor screening plus lab testing for HIV‑1/2 (antibody/antigen and NAT), hepatitis B and C, syphilis, HTLV‑I/II, and, for reproductive HCT/P donors, Chlamydia and Gonorrhea; anonymous donor semen must be quarantined and the donor re‑tested at least six months later before release. Idaho law separately requires HIV antibody testing (via the statute’s HTLV‑III reference) as a condition of use. ([fda.gov](https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/testing-donors-human-cells-tissues-and-cellular-and-tissue-based-products-hctp-specific-requirements?utm_source=openai))